GeneDx Holdings Corp.
Healthcare · Diagnostics & Research
GeneDx Holdings Corp., a genomics company, provides genetic testing services. It primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. The company also develops an AI-based platform for NGS analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. The company is headquartered in Stamford, Connecticut.
Open an account and get free stocks
Affiliate disclosure: We may receive compensation when you sign up through these links.
36
Total Trades
36
Buy Orders
1.04M shares
0
Sell Orders
0.00M shares
+1.04M
Net Position
| Date | Type | Fund | Shares | % of Fund |
|---|---|---|---|---|
| Dec 9 | Buy | ARKG | 1,653 | 0.020% |
| Dec 8 | Buy | ARKG | 4,289 | 0.053% |
| Dec 8 | Buy | ARKK | 3,304 | 0.007% |
| Dec 5 | Buy | ARKG | 31,296 | 0.377% |
| Dec 5 | Buy | ARKK | 20,200 | 0.041% |
| Dec 4 | Buy | ARKG | 6,033 | 0.076% |
| Dec 4 | Buy | ARKK | 3,453 | 0.007% |
| Dec 3 | Buy | ARKG | 15,064 | 0.199% |
| Dec 3 | Buy | ARKK | 8,660 | 0.019% |
| Nov 24 | Buy | ARKG | 6,744 | 0.091% |
| Nov 24 | Buy | ARKK | 4,070 | 0.009% |
| Nov 21 | Buy | ARKG | 7,442 | 0.094% |
| Nov 21 | Buy | ARKK | 4,738 | 0.010% |
| Nov 20 | Buy | ARKG | 7,887 | 0.097% |
| Nov 20 | Buy | ARKK | 4,900 | 0.009% |
| Oct 16 | Buy | ARKG | 17,134 | 0.158% |
| Oct 6 | Buy | ARKG | 19,875 | 0.202% |
| Aug 19 | Buy | ARKG | 1,667 | 0.019% |
| Aug 19 | Buy | ARKK | 124,669 | 0.174% |
| Aug 18 | Buy | ARKG | 2,900 | 0.034% |
| Aug 18 | Buy | ARKK | 167,571 | 0.208% |
| Aug 15 | Buy | ARKG | 632 | 0.007% |
| Aug 15 | Buy | ARKK | 48,224 | 0.046% |
| Aug 14 | Buy | ARKG | 284 | 0.003% |
| Aug 14 | Buy | ARKK | 25,127 | 0.030% |
| Aug 13 | Buy | ARKG | 17,723 | 0.205% |
| Aug 12 | Buy | ARKG | 20,490 | 0.236% |
| Aug 6 | Buy | ARKG | 23,005 | 0.243% |